Panhypogammaglobulinaemia Caused by Gold Therapy
| Autor: | Stewart Ic, Pearson Sl, Kellett Rj |
|---|---|
| Rok vydání: | 1988 |
| Předmět: |
Male
medicine.medical_specialty Immunoglobulin levels 030204 cardiovascular system & hematology Hypoglobulinaemia Injections Intramuscular Gastroenterology Gold Sodium Thiomalate Arthritis Rheumatoid 03 medical and health sciences 0302 clinical medicine Gold Compounds Agammaglobulinemia Internal medicine medicine Humans In patient 030212 general & internal medicine biology business.industry Gold Therapy General Medicine Middle Aged medicine.disease Discontinuation Rheumatoid arthritis biology.protein Antibody business |
| Zdroj: | Scottish Medical Journal. 33:343-344 |
| ISSN: | 2045-6441 0036-9330 |
| DOI: | 10.1177/003693308803300516 |
| Popis: | Gold compounds have been successfully used for over 50 years in the treatment of rheumatoid arthritis, but their mechanism of action is unknown. The main disadvantage is the frequent occurrence of side effects which often necessitate discontinuation of therapy.1 Recently, there have been reports of reduction in immunoglobulin levels in patients on gold treatment; we report a further case of hypoglobulinaemia associated with gold therapy and recommend that immunoglobulins be monitored prior to and during treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|